You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Major Bleeding

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

"ORBIT" Versus "HAS-BLED" Scores in Predicting Major Bleeding in

Not yet recruiting
  • Patients With Atrial Fibrillation Receiving Oral Anticoagulants
  • (no location specified)
Jul 27, 2023

Health Care Interventions and Outcomes of Major Bleedings in

Not yet recruiting
  • Major Bleeding
  • None (Observational study)
  • (no location specified)
Nov 17, 2023

Bleeding Disorder Trial in Charlottesville (Recombinant von Willebrand Factor)

Not yet recruiting
  • Bleeding Disorder
  • Recombinant von Willebrand Factor
  • Charlottesville, Virginia
    UVA Hospital
Nov 3, 2023

Traumatic Injury Trial (BE1116, Placebo)

Not yet recruiting
  • Traumatic Injury
  • (no location specified)
Oct 3, 2022

NOAC Portuguese Real World Study

Withdrawn
  • Stroke
  • +2 more
  • (no location specified)
Apr 8, 2022

Major Bleeding in Participants Who Received Blood Thinning

Completed
  • Venous Thromboembolism (VTE)
    • Princeton, New Jersey
      Local Institution
    Feb 10, 2022

    Hemorrhage, Blood Component Transfusion Trial in Silkeborg, Aarhus (Blood products)

    Recruiting
    • Hemorrhage
    • Blood Component Transfusion
    • Blood products
    • Silkeborg, Midtjylland, Denmark
    • +1 more
    Oct 5, 2021

    Ventilator Lung, Liver Cirrhosis, Hepatocellular Carcinoma Trial in Seoul (conventional tidal volume (tidal volume [ml]= ideal

    Not yet recruiting
    • Ventilator Lung
    • +3 more
    • conventional tidal volume (tidal volume [ml]= ideal body weight [kg]* 10~12) group
    • low tidal (tidal volume [ml]= ideal body weight [kg] * 6~8) volume
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Aug 3, 2022

    Thromboembolic Events in Patients Receiving Kcentra® or Plasma

    Completed
    • Hemorrhage
    • Kcentra®
    • Plasma
    • Oakland, California
      Study Site
    May 24, 2021

    Hemophilia Trial (Coagulation Factor VIIa (Recombinant))

    Not yet recruiting
    • Hemophilia
    • Coagulation Factor VIIa (Recombinant)
    • (no location specified)
    Jan 12, 2023

    MACCE According to Time Interval of Taking Medication in Acute

    Completed
    • Acute Coronary Syndrome or B Cerebral Infarction Requiring DAPT(Clopidogrel + Aspirin) for at Least 6 Months
    • Esomezol Cap
    • Seoul, Korea, Republic of
      Hanmi Pharmaceutical Company Limited
    Aug 2, 2022

    The Major Bleeding Risk Following Hepatectomy

    Completed
    • Gastrointestinal Hemorrhage
    • +2 more
    • hepatectomy
    • Taichung, Taiwan
      China Medical University Hospital
    Feb 8, 2021

    Bleeding Trial in Worldwide (Andexanet)

    Completed
    Has Results
    • Bleeding
    • Andexanet
    • Long Beach, California
    • +86 more
    Jan 25, 2022

    Bleeding Complications of NOACs vs. VKA in Non-valvular Atrial

    Terminated
    • Non-valvular Atrial Fibrillation
    • Rivaroxaban (Xarelto, BAY59-7939)
    • +3 more
    • Multiple Locations, Norway
      Many Locations
    Dec 9, 2020

    Blood Loss, Surgical Trial in France (acid tranexamic, Nacl 0.9%)

    Terminated
    • Blood Loss, Surgical
    • acid tranexamic
    • Nacl 0.9%
    • Amiens, France
    • +3 more
    Feb 24, 2021

    Bleeding Disorder, Hypofibrinogenemia; Acquired Trial in Worldwide (BT524, FFP/Cryo)

    Recruiting
    • Bleeding Disorder
    • Hypofibrinogenemia; Acquired
    • BT524
    • FFP/Cryo
    • Jette, Belgium
    • +17 more
    Mar 28, 2022

    S in Preterm nEonates With thromboCyTopenia (PROSPECT)

    Recruiting
    • Neonatal Thrombocytopenia
    • +2 more
      • Veldhoven, Brabant, Netherlands
      • +10 more
      Sep 15, 2023

      Venous Thromboembolism, Venous Thromboses, Pulmonary Embolism Trial in Netherlands (Randomised treatment advice (discontinue vs

      Recruiting
      • Venous Thromboembolism
      • +3 more
      • Randomised treatment advice (discontinue vs continue after 3 months)
      • +4 more
      • Leiden, South-Holland, Netherlands
      • +16 more
      Oct 17, 2023

      Non-paroxysmal Atrial Fibrillation Trial in Beijing (Thoracoscopic LAA clipping, Novel oral anticoagulant)

      Not yet recruiting
      • Non-paroxysmal Atrial Fibrillation
      • Thoracoscopic LAA clipping
      • Novel oral anticoagulant
      • Beijing, Beijing, China
        China National Center for Cardiovascular Diseases
      Aug 31, 2023

      Peptic Ulcer, Bleeding Trial in Hong Kong (Trans-catheter arterial embolization, Surgery)

      Terminated
      • Peptic Ulcer
      • Bleeding
      • Trans-catheter arterial embolization
      • Surgery
      • Hong Kong, China
        Endoscopy Center, Prince of Wales Hospital
      Jun 21, 2020

      Hemorrhage, Urgent Surgery, Invasive Procedure Trial in Worldwide (Bentracimab (PB2452) Infusion)

      Recruiting
      • Hemorrhage
      • +2 more
      • Bentracimab (PB2452) Infusion
      • Fullerton, California
      • +89 more
      Oct 31, 2022

      Atrial Fibrillation, Coronary Artery Disease Trial (Rivaroxaban)

      Not yet recruiting
      • Atrial Fibrillation
      • Coronary Artery Disease
      • (no location specified)
      Oct 22, 2023

      Ischemic Stroke, Anticoagulant Adverse Reaction Trial in Taipei (Dabigatran, rivaroxaban, apixaban, edoxaban)

      Recruiting
      • Ischemic Stroke
      • Anticoagulant Adverse Reaction
      • Dabigatran, rivaroxaban, apixaban, edoxaban
      • Taipei, Taiwan
        National Taiwan University Hospital
      Nov 22, 2023

      Compare Health Care Costs Between Apixaban and Low Molecular

      Active, not recruiting
      • Thromboembolism
        • New York, New York
          Pfizer Investigational
        Dec 1, 2022

        Patient Outcome in Major Abdominal Surgery

        Completed
        • Surgical Site Infection
        • Bleeding
        • Prevention of hypothermia
        • Bergen, Hordaland, Norway
        • +1 more
        Jun 19, 2020